Le Lézard
Classified in: Health, Covid-19 virus
Subject: MRR

Global Dental Insurance Market Report 2022-2027: Featuring Profiles of Aetna, Aflac, Allianz, Cigna, Delta, Dental Plans Association and MetLife


DUBLIN, April 19, 2022 /PRNewswire/ -- The "Dental Insurance Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The global dental insurance market reached a value of US$ 173.2 Billion in 2021. Looking forward, the market is forecast to reach US$ 290.5 Billion by 2027, exhibiting a CAGR of 8.60% during 2022-2027.

The increasing prevalence of various oral disorders, such as gingivitis, tooth decay, oral cancer and broken teeth, is one of the key factors driving the growth of the market. With the changing dietary patterns and increasing consumption of sugary compounds, there is a rising incidence of gum disease and cavities. This has led to the widespread adoption of dental insurance policies to cover treatment expenditures and obtain premium-quality care.

Moreover, various product innovations, such as the development of customized insurance plans that cover regular check-ups of the patients and offer affordable, more accessible and higher quality care, are providing a thrust to the market growth. In line with this, the increasing utilization of artificial intelligence (AI) to enable hyper-accurate, liability-free diagnostics and develop comprehensive insurance policies are positively impacting the market growth.

Other factors, including the increasing demand for regular dental check-ups and significant growth in the healthcare industry, along with the implementation of various government initiatives to formalize dentalcare services, are anticipated to drive the market toward growth.

Key Questions Answered in this Report:

Competitive Landscape: The competitive landscape of the industry has also been examined along with the profiles of the key players being Aetna Inc. (CVS Health Corporation), Aflac Inc., Allianz SE, Ameritas Life Insurance Corp., Axa S.A., Cigna, Delta Dental Plans Association, MetLife Inc., United Concordia (Highmark Inc.) and United HealthCare Services Inc.

The report provides an analysis of the key trends in each sub-segment of the global dental insurance market, along with forecasts at the global, regional and country level from 2022-2027. 

Breakup by Type:

Breakup by Coverage:

Breakup by Demographics:

Breakup by End User:

Breakup by Region:

For more information about this report visit https://www.researchandmarkets.com/r/le8v2e

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 01:05
Genoks, a leading Turkish genomics healthcare company, and Velsera, a global healthcare technology company offering a universal software platform to connect clinical care with discovery, have announced a collaboration aimed at advancing cancer...

at 01:04
Sirnaomics Ltd. (the "Company", together with its subsidiaries, the "Group" or "Sirnaomics"; stock code: 2257), a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics, today announced that the Group...

27 jun 2024
Swiss Health & bioBeauty AG, owner of the prestigious beauty and longevity brand NIANCE, announces that internationally renowned supermodel, philanthropist, and investor Natalia Vodianova has become one of the key shareholders of NIANCE. This...

27 jun 2024
Dioseve Inc. (Headquarters: Tokyo; CEO: Kazuma Kishida; hereinafter "the Company"), aiming to develop assisted reproductive technology using oocytes derived from iPS cells, has raised 7 million USD. This was achieved through third-party allotment of...

27 jun 2024
In his groundbreaking new book, "This Book Will Save Your Life: The New Medical Cure for Opioid Addiction," Dr. Russell Surasky, a double board-certified neurologist and addiction medicine specialist, unveils a revolutionary new medical treatment for...

27 jun 2024
BioArctic AB's (publ) partner Eisai today announced today that Leqembi® (brand name in China:  "???®", generic name: lecanemab) has been launched in China. Leqembi received approval in January 2024 as a treatment of mild cognitive impairment (MCI)...



News published on and distributed by: